Browse by all authors Browse By Author Name - Peleg,+Anton+Y.

Browse Results (11 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Peleg, Anton Y., Seifert, Harald and Paterson, David L. (2008) Acinetobacter baumannii: Emergence of a successful pathogen. Clinical Microbiology Reviews, 21 3: 538-582. doi:10.1128/CMR.00058-07 56   758 Cited 862 times in Scopus862 17
Paterson, David L., Potoski, Brian A. and Peleg, Anton Y. (2009) Cefepime MIC breakpoint resettlement in gram-negative bacteria - Reply. Antimicrobial Agents and Chemotherapy, 53 1: 337-338. doi:10.1128/AAC.00106-08 54   0 Cited 0 times in Scopus0 0
Peleg, Anton Y., Weerarathna, Thilak, McCarthy, James S. and Davis, Timothy M. E. (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes/Metabolism Research & Reviews, 23 1: 3-13. doi:10.1002/dmrr.682 147   83 Cited 104 times in Scopus104 0
Potoski, Brian A., Adams, Jennifer, Clarke, Lloyd, Shutt, Kathleen, Linden, Peter K., Baxter, Carla, Pasculle, A. William, Capitano, Blair, Peleg, Anton Y., Szabo, Dora and Paterson, David L. (2006) Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. Clinical Infectious Diseases, 43 2: 165-171. doi:10.1086/505114 35   57 Cited 68 times in Scopus68 0
Bhat, Sunil V., Peleg, Anton Y., Lodise, Thomas P., Shutt, Kathleen A., Capitano, Blair, Potoski, Brian A. and Paterson, David L. (2007) Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms. Antimicrobial Agents And Chemotherapy, 51 12: 4390-4395. doi:10.1128/AAC.01487-06 90   58 Cited 62 times in Scopus62 0
Baek-Nam, Kim, Peleg, Anton Y., Lodise, Thomas P., Lipman, Jeffrey, Li, Jian, Nation, Roger and Paterson, David L. (2009) Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infectious Diseases, 9 4: 245-255. doi:10.1016/S1473-3099(09)70055-6 99   54 Cited 61 times in Scopus61 0
Harris, Patrick N. A., Peleg, Anton Y., Iredell, Jon, Ingram, Paul R., Miyakis, Spiros, Stewardson, Andrew J., Rogers, Benjamin A., McBryde, Emma S., Roberts, Jason A., Lipman, Jeff, Athan, Eugene, Paul, Sanjoy K., Baker, Peter, Harris-Brown, Tiffany and Paterson, David L. (2015) Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials, 16 . doi:10.1186/s13063-014-0541-9 13   0 5
Peleg, Anton Y. and Paterson, David L. (2006) Modifying antibiotic prescribing in primary care. Clinical Infectious Diseases, 42 9: 1231-1233. doi:10.1086/503042 27   4 Cited 2 times in Scopus2 0
Lim, Ching Jou, Cheng, Allen C., Kennon, Jacqueline, Spelman, Denis, Hale, Dayna, Melican, Gabrielle, Sidjabat, Hanna E., Paterson, David L., Kong, David C. M. and Peleg, Anton Y. (2014) Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: A nested case-control study. Journal of Antimicrobial Chemotherapy, 69 7: 1972-1980. doi:10.1093/jac/dku077 16   2 Cited 2 times in Scopus2 4
Peleg, Anton Y., de Breij, Anna, Adams, Mark D., Cerqueira, Gustavo M., Mocali, Stefano, Galardini, Marco, Nibbering, Peter H., Earl, Ashlee M., Ward, Doyle V., Paterson, David L., Seifert, Harald and Dijkshoorn, Lenie (2012) The success of Acinetobacter species; genetic, metabolic and virulence attributes. Plos One, 7 10: e46984-1-e46984-11. doi:10.1371/journal.pone.0046984 44   22 Cited 23 times in Scopus23 1
Peleg, Anton Y., Adams, Jennifer and Paterson, David L. (2007) Tigecycline efflux as a mechanism for nonsusceptibility in acinetobacter baumannii. Antimicrobial Agents & Chemotherapy, 51 6: 2065-2069. doi:10.1128/AAC.01198-06 84   98 Cited 103 times in Scopus103 0